PerkinElmer Shares Rise on Upgrade

Aug 13, 2009

NEW YORK (GenomeWeb News) – Shares of PerkinElmer were up 5 percent in late Thursday afternoon trade on the New York Stock Exchange after investment bank Thomas Weisel Partners upgraded the firm's stock to "overweight" from "market weight."

Peter Lawson, an analyst for the bank, also raised his price target on PerkinElmer's shares to $20 from his previous target of $18.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Synthetic Genomics Sued for Gender Discrimination

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Football Team's DNA Day Postponed

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

To Interfere

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

This Week in Cell

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.

Main menu